跳至主要内容
临床试验/NCT05779982
NCT05779982已完成不适用

Outcomes of Sentinel Node Biopsy According to MRI Response in an Association With the Subtypes in cN1-3 Breast Cancer After Neoadjuvant Systemic Therapy

Gangnam Severance Hospital0 个研究点目标入组 500 人开始时间: 2013年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
500
主要终点
False negative rate of sentinel lymph node biopsy according to radiologic response stratified by brest cancer subtype

研究概览

简要总结

This study aimed to determine whether sentinel lymph node biopsy (SLNB) could be a reliable option for evaluating nodal status in patients who had responded well to neoadjuvant systemic therapy (NAST), even if they had initially presented with a high nodal burden. The study investigated the outcomes of SLNB followed by axillary lymph node dissection (ALND) in this patient population, taking into account the response to NAST and the breast cancer subtype.

详细描述

To determine the feasibility of sentinel lymph node biopsy (SLNB) in this study, the investigators evaluated the false-negative rate (FNR) of SLNB. The FNR was calculated as the number of patients with negative SLNs who had a residual disease in the rest of the axillary lymph nodes (ALNs) divided by the total number of patients with residual disease in either the SLNs, the rest of the ALNs, or both: FN/true-positive + FN. The investigators compared the FNR of the SLNB according to the radiologic response measured using breast MRI in each subtype. The investigators further evaluated the FNR in subgroups stratified by clinical nodal stage. Additionally, the investigators assessed additional metastatic ALNs in cases with 1-2 metastatic SLNs through the completion of ALN dissection.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
19 Years 至 90 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • cN1-3 breast cancer at initial presentation
  • received neoadjuvant systemic therapy (NAST)
  • received sentinel lymph node biopsy (SLNB) followed by additional axillary lymph node dissection (ALND)
  • breast MRI performed at baseline and post-NAST.

排除标准

  • case with unavailable data for breast MRI and operation

结局指标

主要结局

False negative rate of sentinel lymph node biopsy according to radiologic response stratified by brest cancer subtype

时间窗: up to 1 month after the breast surgery

False negative rate of sentinel lymph node biopsy according to radiologic response stratified by brest cancer subtype

次要结局

  • False negative rate of sentinel lymph node biopsy according to clinical nodal stage(up to 1 month after the breast surgery)
  • Additional axillary lymph node metastasis rate in patients with 1-2 metastatic sentinel lymph nodes(up to 1 month after the breast surgery)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sung Gwe Ahn

Professor

Gangnam Severance Hospital

相似试验